October 3, 2005

IHV Lecture Series Presents National Cancer Institute Director

Baltimore, MD- UMBI's Institute of Human Virology hosted the 2nd annual Stewart and Marlene Greenebaum lecture series. Dr. Andrew von Eschenbach Director of the National Cancer Institute, presented a talk entitled "Eliminating the Suffering and Death Due to Cancer by 2015". More than 200 people attended the event at Westminster Hall in Baltimore.

The Institute of Human Virology (IHV) is a Center of UMBI, and also affiliated with the School of Medicine at the University of Maryland, Baltimore and the University of Maryland Medical System. IHV was established to create and develop a world-class Program of Excellence focusing on chronic viral diseases and virally linked cancers.

   
(From left to right) Dr. Robert C. Gallo, Director, Institute of Human Virology; Mr. Stewart Greenebaum; Mrs. Marlene Greenebaum; Dr. Andrew von Eschenbach, Director, National Cancer Institute; Dr. Kevin Cullen, Director, University of Maryland Medical System's Greenebaum Cancer Center.

###

Celebrating our 20th anniversary year, UMBI is Maryland's premier biotechnology research institute within the University System of Maryland and was established in 1985. The University of Maryland Biotechnology Institute (UMBI) consists of five major research and education centers and is dedicated to advancing the frontiers of biotechnology. UMBI’s centers of research include: CARB, the Center for Advanced Research in Biotechnology located in Rockville; CBR, the Center for Biosystems Research located in College Park; and COMB, the Center of Marine Biotechnology, MBC, the Medical Biotechnology Center, and IHV, the Institute of Human Virology, all located in Baltimore. For more information, visit www.umbi.umd.edu